Fig. 2
From: Protective effects of Alamandine against doxorubicin-induced liver injury in rats
Immunohistochemical staining of IL-1, IL-6, NF-κB (N), and P53 in liver tissue sections from different experimental groups (magnification ×400). Positive immunoreactivity is indicated by brown staining. Group I (Control) exhibits minimal expression of inflammatory markers. Group III (DOX) demonstrates strong IL-1, IL-6, and NF-κB expression. Group V (DOX + Alamandine) shows reduced staining intensity, indicating the anti-inflammatory effects of alamandine. Group IV (Alamandine) displays staining patterns comparable to the control group